Predictors of blood pressure fall with continuous positive airway pressure (CPAP) treatment of obstructive sleep apnoea (OSA)

Thorax

Volumn 63, Issue 10, 2008, Pages 855-859

  Robinson, G V ^a   Langford, B A ^a   Smith, D M ^a   Stradling, J R ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CAFFEINE;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE FLUCTUATION; BLOOD SAMPLING; BODY MASS; CLINICAL TRIAL; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; HYPOXIA; INTROSPECTION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POSITIVE END EXPIRATORY PRESSURE; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE RATE; SCORING SYSTEM; SLEEP APNEA SYNDROME; SOMNOLENCE; VENOUS BLOOD;

EID: 53649107311     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2007.088096     Document Type: Article

References (39)

1. Stradling JR, Crosby JH. Predictors and prevalence of obstructive sleep apnoea and snoring in 1001 middle aged men. Thorax 1991;46:85-90.
2. Stradling JR, Barbour C, Glennon J, et al. Prevalence of sleepiness and its relation to autonomic evidence of arousals and increased inspiratory effort in a community based population of men and women. J Sleep Res 2000;9:381-8.
3. Engloman HM, Martin SE. Kingshott RN, et al. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax 1998;53:341-5.
4. Engleman HM, Kingston RN, Wraith PK, et al. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild Sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999;159:461-7.
5. Jenkinson C, Davies RJ, Mullins R, et al. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive Sleep apnoea: a randomised prospective parallel trial. Lancet 1999;353:2100-5.
6. Nieto FJ, Young TB, Lind BK, et al. Association of Sleep-disordered breathing, Sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000;283:1829-36.
7. Davies CW, Crosby JH, Mullins RL, et al. Case-control study of 24 hour ambulatory blood pressure in patients with obstructive Sleep apnoea and normal matched control subjects. Thorax 2000;55:736-40.
8. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive Sleep apnoea: a randomised parallel trial. Lancet 2002;359:204-10.
9. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive Sleep apnea. Circulation 2003;107:68-73.
10. Faccenda JF, Mackay TW, Boon NA, et al. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the Sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001;163:344-8.
11. Barbe F, Mayoralas LR, Duran J, et al. Treatment with continuous positive airway pressure is not effective in patients with Sleep apnea but no daytime Sleepiness, a randomized, controlled trial. Ann Intern Med 2001;134:1015-23.
12. Dimsdale JE, Loredo JS, Profant J. Effect of continuous positive airway pressure on blood pressure: a placebo trial. Hypertension 2000;35:144-7.
13. Monasterio C, Vidal S, Duran J, et al. Effectiveness of continuous positive airway pressure in mild Sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001;164:939-43. 0
14. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive Sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-53.
15. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-74.
16. Hedner J, Darpo B, Ejnell H, et al. Reduction in sympathetic activity after long-term CPAP treatment in Sleep apnoea: cardiovascular implications, Eur Respir J 1995;8:222-9.
17. Jennum P, Wildschiodtz G, Christensen NJ, et al. Blood pressure, catecholamines, and pancreatic polypeptide in obstructive Sleep apnea with and without nasal continuous positive airway pressure (nCPAP) treatment. Am J Hypertens 1989;2:847-52.
18. Lea S, Ali NJ, Goldman M, et al. Systolic blood pressure swings reflect inspiratory effort during simulated obstructive Sleep apnoea. In: Home J, ed. Sleep 90. Bochum: Pontenagel Press, 1990:178-81.
19. Stradling JR, Barbour C, Glennon J, et al. Which aspects of breathing during Sleep influence the overnight fall of blood pressure in a community population. Thorax 2000;55:393-8.
20. Robinson GV, Smith DM, Langford BA, et al. CPAP does not reduce blood pressure in non-Sleepy hypertensive OSA patients. Eur Respir J 2006;27:1-7.
21. Pitson DJ, Sandell A, van den Hout R, et al. Use of pulse transit time as a measure of inspiratory effort in patients with obstructive Sleep apnoea. Eur Respir J 1995;8:1669-74.
22. Pitson DJ, Stradling JR. Autonomic markers of arousal during Sleep in patients undergoing investigation for obstructive Sleep apnoea, their relationship to EEG arousals, respiratory events and subjective Sleepiness. J Sleep Res 1998;7:53-60.
23. Bennett LS, Langford BA, Stradling JR, et al. Sleep fragmentation indices as predictors of daytime Sleepiness and nCPAP response in obstructive Sleep apnea. Am J Respir Crit Care Med 1998;158:778- 86.
24. Vazquez JC, Tsai WH, Flemons WW, et al. Automated analysis of digital oximetry in the diagnosis of obstructive Sleep apnoea. Thorax 2000;55:302-7.
25. Stradling J, Smith D, Radulovacki M, et al. Effect of ondansetron on moderate obstructive Sleep apnoea, a single night, placebo-controlled trial. J Sleep Res 2003;12:169-70.
26. O'Brien E, Mee F, Atkins N, et al. Accuracy of the Takeda TM-2420/TM-2020 determined by the British Hypertension Society protocol. J Hypertens 1991;9:571-2.
27. Johns MW, A new method for measuring daytime Sleepiness: the Epworth Sleepiness scale. Sleep 1991;14:540-5.
28. Ayas NT, Patel SR, Malhotra A, et al. Auto-titrating versus standard continuous positive airway pressure for the treatment of obstructive Sleep apnea: results of a meta-analysis. Sleep 2004;27:249-53.
29. Landrum RE, College students' use of caffeine and its relationship to personality. College Student J 1992;26:151-5.
30. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998;21:2191-2.
31. Altman DG, Practical statistics for medical research. London: Chapman and Hall, 1991.
32. West SD, Jones DR, Stradling JR. Comparison of three ways to determine and deliver pressure during nasal CPAP therapy for obstructive Sleep apnoea. Thorax 2006;61:226-31.
33. Mills PJ, Kennedy BP, Loredo JS, et al. Effects of nasal continuous positive airway pressure and oxygen supplementation on norepinephrine kinetics and cardiovascular responses in obstructive Sleep apnea. J Appl Physiol 2006;100:343-8.
34. Choi JB, Nelesen R, Loredo JS, et al. Sleepiness in obstructive Sleep apnea: a harbinger of impaired cardiac function? Sleep 2006;29:1531-6.
35. Norman D, Loredo JS, Nelesen RA, et al. Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure. Hypertension 2006;47:840-5.
36. Egan BM, Insulin resistance and the sympathetic nervous system. Curr Hypertens Rep 2003;5:247-54.
37. Rees K, Spence DPS, Earis JE, et al. Arousal responses from apneic events during non rapid-eye-movement Sleep. Am J Respir Crit Care Med 1995;152:1016-21.
38. Oishi M, Suwazono Y, Sakata K, et al. A longitudinal study on the relationship between shift work and the progression of hypertension in male Japanese workers. J Hypertens 2005;23:2173-8.
39. Goldstein IB, Ancoli-Israel S, Shapiro D. Relationship between daytime Sleepiness and blood pressure in healthy older adults. Am J Hypertens 2004;17:787-92.